Back to PRLD

Affinity Asset Advisors, LLC → PRLD

Affinity Asset Advisors, LLC PRLD Position History

Prelude Therapeutics Incorporated • Healthcare

Quarters held
1
Latest value
$10.2M
Q3 2026
Peak value
$10.2M
First seen
Q3 2026

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$10.2M2.60M——

Other funds holding PRLD

Other Affinity Asset Advisors, LLC positions

ROIV

ROIVANT SCIENCES LTD

$132.7M
APGE

APOGEE THERAPEUTICS INC

$131M
ROIV

ROIVANT SCIENCES LTD

$117M
SYRE

SPYRE THERAPEUTICS INC

$113.9M
SYRE

SPYRE THERAPEUTICS INC

$113.6M
APGE

APOGEE THERAPEUTICS INC

$108.2M
XENE

XENON PHARMACEUTICALS INC

$97.4M
XENE

XENON PHARMACEUTICALS INC

$96.3M